Vilazodone Hydrochloride

盐酸维拉佐酮

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameVilazodone Hydrochloride
Drug Alias Name维拉唑酮vilazodona维拉佐酮盐酸盐vilazodonum盐酸维拉唑酮 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin reuptake inhibitors
TargetsSerotonin 1a (5-HT1a) receptorSerotonin transporter
Therapy Area/IndicationsStress Disorders, Post-TraumaticDepressive Disorder, MajorDepressive Disorder +[7] 
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/01/21
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesForest Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlobal Coalition For Adaptive Research IncJiangsu Hansoh Pharmaceutical Group Co LtdAbbvie Inc +[5] 
Inactive CompaniesGenaissance PharmaceuticalsUniversity of Texas Southwestern Medical CenterDuke University +[7] 
Active IndicationsStress Disorders, Post-TraumaticDepressive Disorder, MajorDepressive Disorder +[4] 
Inactive IndicationsAnxiety DisordersMarijuana AbuseMemory Disorders

Other Information

ATC CodeN06AX24
Related LinksWikipediaDrugBankKEGG